Headline: New PLA CPT code 0518U identifies a proprietary plasma drug panel for pain and mental health medication monitoring

Lead: CPT code 0518U designates SyncView® Pain, a proprietary LC–MS/MS plasma assay from Phenomics Health™ Inc. that quantifies 90+ drugs relevant to pain management and mental health. The code enables reporting of this single-manufacturer laboratory test on claims and is relevant to payers and providers managing complex medication regimens.

What the code represents and why it matters: As a PLA CPT code, 0518U is tied to a unique commercial test and facilitates precise claims reporting for advanced toxicology and therapeutic drug monitoring. Nationally, accurate coding for high-complexity laboratory diagnostics supports administrative tracking, utilization oversight, and clinical case management for patients on multiple analgesic and psychotropic agents.

Key payers covered in the analysis: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare are the primary payers referenced for coverage and claims processing context.

Overview of what readers will learn: This publication explains the clinical scope of the test, its service setting and billing implications, and what to expect in payers’ administrative handling of a PLA-coded LC–MS/MS panel. Readers will find benchmarks and contextual guidance on coding and claims reporting practices, policy considerations for proprietary laboratory tests, and the clinical relevance of broad-spectrum drug quantitation for pain and mental health management.